Hair loss terms: a glossary that separates the clinical words from the clinic's marketing

At 2am, the same word can sound clinical, reassuring, or expensive depending on who says it.

CLINICAL means a term with a stable meaning in medical literature or on a drug label. DESCRIPTIVE means useful shorthand with moving boundaries. SALES means a word used mainly to market a product or procedure, not a diagnosis.

Norwood comes from O'Tar T. Norwood's 1975 classification paper in the Southern Medical Journal: a way for two doctors to describe the same head, not a rank, fate, or number.

The short version

• The key distinction: shedding is a hair leaving; miniaturisation is a follicle producing thinner hair over time.
• The provenance test: a label can be useful without being a diagnosis; ask where it comes from.
• Norwood is descriptive: it names a visible pattern, not your value or destination.
• A number needs a job: density, calibre, and a scale describe anatomy; a promised outcome is separate.
• The sensible next step: identify the pattern, then ask what evidence and label support it.

Table of contents

• The hair itself
• Diagnoses
• The measuring words
• The molecules
• The procedures
• The forum words
• Which of these words should change what you do?
• The bottom line
• Sources

The hair itself

These terms describe the hair cycle, follicle, and temporary shed versus a changing follicle. The hair-growth physiology reference is a clinical starting point. The most commonly confused pair of terms here gets a full treatment in maturing hairline vs balding.

• [CLINICAL] Anagen: Anagen is the active growth phase in which the shaft is produced.
• [CLINICAL] Catagen: Catagen is the transition between active growth and rest.
• [CLINICAL] Telogen: Telogen is the resting phase; a hair can later be shed.
• [CLINICAL] Terminal hair: Terminal hair is thicker, mature hair that contributes most to coverage.
• [CLINICAL] Vellus hair: Vellus hair is fine and short-looking; vellus-like output can make an area look less covered.
• [CLINICAL] Follicle: A follicle produces hair; losing a shaft is not the same as losing follicular output.
• [CLINICAL] Miniaturisation: Miniaturisation means a follicle produces progressively finer hair; it is a process, not a Norwood identity.
• [CLINICAL] Hair density: Density is how many hairs occupy an area; calibre is shaft thickness.
• [CLINICAL] Hair calibre: Calibre is the thickness of an individual shaft. Low calibre can reduce coverage despite reasonable density.
• [CLINICAL] Shedding versus loss: A shed hair can regrow; miniaturisation produces a thinner hair each cycle.

Diagnoses

A diagnosis names a pattern or process; “more hair in the shower” is a symptom. Take these terms to a clinician, not a forum label.

• [CLINICAL] Androgenetic alopecia: Androgenetic alopecia is patterned hair loss associated with inherited sensitivity and androgen signalling; see StatPearls, not a clinic caption.
• [CLINICAL] Telogen effluvium: Telogen effluvium is diffuse shedding linked to a hair-cycle shift, not every kind of thinning; see its clinical reference.
• [CLINICAL] Anagen effluvium: Anagen effluvium is shedding during the active growth phase, distinct from telogen effluvium.
• [CLINICAL] Alopecia areata: Alopecia areata is an autoimmune form of hair loss affecting scalp hair; NIAMS is the patient reference.
• [CLINICAL] Traction alopecia: Traction alopecia is hair loss associated with repeated pulling or tension; “traction” is not a synonym for recession.
• [CLINICAL] Scarring, or cicatricial, alopecia: Scarring alopecia is hair loss in which the follicle is damaged and replaced by scar tissue. “Cicatricial” is the medical word.
• [CLINICAL] Seborrhoeic dermatitis: Seborrhoeic dermatitis is an inflammatory scalp condition involving scale, redness, or irritation; it is different from hair loss.

The measuring words

Measurement terms make observations more precise, but mislead when a descriptive scale becomes an identity or promise.

• [CLINICAL] Norwood scale / Norwood-Hamilton: The Norwood classification describes common male hairline and crown patterns. Norwood's 1975 paper is the provenance; keep the original DOI beside charts.
• [CLINICAL] Ludwig scale: The Ludwig scale classifies female-pattern thinning. It is a communication tool, not a measure of attractiveness.
• [SALES/forum] “Norwood 2” as an identity: “Norwood 2” can identify a pattern, but a classification is not a fate.
• [CLINICAL] Hair pull test: A hair pull test assesses shedding in clinical context, not as a home contest with fixed meaning.
• [CLINICAL] Trichoscopy: Trichoscopy is magnified examination of the scalp and hair, revealing features distance cannot show.
• [CLINICAL] Phototrichogram: A phototrichogram uses standardized photographs over time to examine hair growth and change; comparable images matter.
• [DESCRIPTIVE] Donor density: Donor density describes hair in a proposed donor area; the number alone does not settle suitability.
• [DESCRIPTIVE] Donor area: The donor area is the scalp region considered available for harvesting. “Available” is not unlimited.

The molecules

Molecule names identify a substance or pathway, not whether it is right for you. For label language, use the finasteride and minoxidil entries at DailyMed.

• [CLINICAL] DHT: DHT is dihydrotestosterone, an androgen involved in signalling and discussed in relation to androgenetic alopecia.
• [CLINICAL] 5-alpha reductase: 5-alpha reductase is an enzyme converting testosterone into DHT; it is a pathway, not a treatment name.
• [CLINICAL] Finasteride: Finasteride is a 5-alpha reductase inhibitor. Approved use and warnings belong to the prescribing label.
• [CLINICAL] Dutasteride: Dutasteride is also a 5-alpha reductase inhibitor. Comparing it with finasteride should separate drug class from personal recommendation.
• [CLINICAL] Minoxidil: Minoxidil is a hair-growth medicine available in topical forms and discussed in oral form; it is not a universal regimen.
• [CLINICAL] Ketoconazole: Ketoconazole is an antifungal medicine often mentioned for scalp care, not a substitute for diagnosing patterned loss.

The procedures

Procedures change hair arrangement, appearance, or local environment; sales language can turn that action into a promised transformation. Separate technique from outcome.

• [CLINICAL] FUE: FUE, or follicular unit extraction, removes follicular units individually from a donor area.
• [CLINICAL] FUT / strip: FUT, or strip surgery, removes a strip of donor scalp for dissection into follicular units.
• [CLINICAL] Graft: A graft is transplanted tissue containing hair follicles; graft count is not the number of hairs inside each graft.
• [CLINICAL] Follicular unit: A follicular unit is the natural grouping in which scalp hairs grow and the biological unit used in planning.
• [DESCRIPTIVE] Donor dominance: Donor dominance is the idea that transplanted donor hair retains its characteristics in a new location; donor supply is not infinite.
• [CLINICAL] Shock loss: Shock loss is temporary or persistent shedding after a scalp procedure or local trauma, not a recovery stage.
• [SALES] Scalp micropigmentation: Scalp micropigmentation places pigment to create the visual impression of hair or density. It changes appearance rather than restoring a follicle.
• [SALES] Hair systems: Hair systems are non-surgical hairpieces that cover or replace visible hair. “System” is not a diagnosis.
• [CLINICAL] PRP: PRP means platelet-rich plasma prepared from blood for injection; the acronym identifies material and procedure, not a result.
• [CLINICAL] Microneedling for hair: Microneedling creates controlled skin punctures; technique and evidence for a particular use should remain separate.
• [DESCRIPTIVE] “Density per cm²”: This is a real consult measurement; the number is not the promise built around it.

The forum words

Forum language helps people compare photographs. Treat it as description unless a clinician gives the word a diagnostic meaning.

• [DESCRIPTIVE] Hairline maturation: Hairline maturation is a real phenomenon: the juvenile hairline moves back in early adulthood in many men. It is not a diagnosis and can delay a needed consult.
• [DESCRIPTIVE] Recession versus receding: Recession names the visible shape of a hairline moving back; receding describes the process. Neither explains the cause.
• [DESCRIPTIVE] Widow's peak: A widow's peak is a central point or V-shape in the hairline, which can be normal rather than active loss.
• [DESCRIPTIVE] Crown versus vertex: Crown and vertex are everyday terms for the upper-back scalp. A consult should clarify the photographed area.
• [SALES/forum] “NW3 cope”: “NW3 cope” is forum rhetoric, not a diagnosis; ask for the actual observation.
• [DESCRIPTIVE] Slick bald: Slick bald means the scalp appears smooth and visibly bare. It is shorthand, not a clinical classification.
• [DESCRIPTIVE] Buzzed versus shaved: Buzzed hair is cut very short; shaved hair is closer to the skin. Photographs should state which you are seeing.
• [DESCRIPTIVE] Diffuse thinning: Diffuse thinning means reduced-looking coverage spread across an area. It describes distribution, not cause.

Which of these words should change what you do?

Words that should change your next step identify a process, drug label, or genuine procedural choice. Words that create urgency should make you slow down.

For treatment questions, start with the diagnosis and label. For numerical evidence, use the hair loss treatment statistics page rather than asking a glossary for figures it does not contain.

Hairline anxiety is real, but a hairline is not a verdict. Use this material for orientation, not anxiety.

Hair reads fast in a first impression, but what reads is the whole frame: grooming, fit, and how settled you look. That is what /test shows you: how a photo reads rather than scoring you.

The bottom line

The useful question is not “What number am I?” but “What does this word describe, and who benefits if I misunderstand it?” Clinical terms clarify a decision; descriptive terms organize a conversation; sales terms sell.

Norwood can help two doctors describe the same head. It cannot tell you your value, future, or correct response. If you are considering a procedure, treatment, or haircut, separate the pattern from the pitch.

Sources

• O'Tar T. Norwood (1975), “Male Pattern Baldness: Classification and Incidence,” Southern Medical Journal. https://doi.org/10.1097/00007611-197511000-00009
• StatPearls, “Androgenetic Alopecia.” https://www.ncbi.nlm.nih.gov/books/NBK430924/
• Endotext, “Male Androgenetic Alopecia.” https://www.ncbi.nlm.nih.gov/books/NBK278957/
• StatPearls, “Telogen Effluvium.” https://www.ncbi.nlm.nih.gov/books/NBK430848/
• StatPearls, “Anagen Effluvium.” https://www.ncbi.nlm.nih.gov/books/NBK482293/
• StatPearls, “Physiology, Hair.” https://www.ncbi.nlm.nih.gov/books/NBK499948/
• National Institute of Arthritis and Musculoskeletal and Skin Diseases, “Alopecia Areata.” https://www.niams.nih.gov/health-topics/alopecia-areata
• MedlinePlus, “Male Pattern Baldness.” https://medlineplus.gov/ency/article/001177.htm
• DailyMed, finasteride prescribing labels. https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=finasteride
• DailyMed, minoxidil labels. https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=minoxidil